Duygu Mert

8PUBLICATIONS
16CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsChiropractic
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 12, 2026
Evaluation of colonization with multidrug-resistant microorganisms and the incidence of attributable infections in patients undergoing hematopoietic stem cell transplantation.

Burcu Çalişkan Demirkiran, Gülşen Iskender, İpek Mumcuoğlu

|May 30, 2024
COVID-19 in cancer patients: patient characteristics and outcomes in the post-COVID-19 vaccination period.

Gülşen Iskender, Duygu Mert, Göknur Yapar Toros

|Apr 07, 2023
Evaluation of risk factors, causative pathogens, and treatment in recurrent percutaneous nephrostomy catheter-related urinary tract infections in cancer patients.

Duygu Mert, Gulsen Iskender, Servet Kolgelier

|Nov 19, 2022
Latent tuberculosis in adult hematopoietic stem cell transplantation recipients: Clinical experience from a previously endemic population.

Duygu Mert, Muhammet Ozer, Alparslan Merdin

|Jan 17, 2022
Evaluation of awareness about importance of high fever in leukemia and lymphoma patients receiving chemotherapy among healthcare professionals working in pharmacies other than hospital pharmacies: A survey from a Central Anatolian city.

Duygu Mert, Alparslan Merdin

|Aug 28, 2020
Evaluation of HBV, HCV, and HIV seroprevalence in patients with plasma cell disorders.

Duygu Mert, Alparslan Merdin, Merih Kizil Çakar

Pageof 2

Frequent Collaborators

2 joint publications

Alparslan Merdin

2 joint publications

Gülşen Iskender

2 joint publications

Semra Tunçbilek

2 joint publications

Mustafa Ertek